High-yield savings accounts are another possible option for funds from a maturing CD — and a better choice than long-term CDs ...

French pharma major Sanofi has opened negotiations to sell a 50% controlling stake in its consumer health business Opella to ...

France will take a stake in Sanofi's Opella through the Public Investment Bank (BPI), finance minister Antoine Armand said on ...

Sanofi (EPA:SASY)(NASDAQ:SNY) has entered into exclusive negotiations with private equity firm Clayton, Dubilier&Rice to sell a controlling stake in its consumer healthcare unit, Opella, the company ...

Instead, if you aren’t able to keep your money locked for the certificate’s entire term, you must sell your CD on the secondary market. Note the potential costs involved in selling your CD.

Sanofi said it entered talks to sell a controlling stake in consumer health business Opella to private-equity firm Clayton ...

Sanofi and private equity firm CD&R are in negotiations to sell a 50% stake in Opella, Sanofi's consumer healthcare division. With a €16B valuation, Opella is the third-largest player in the global ...

you'll sell your CD on the secondary market. Brokered CDs typically offer flexible terms and higher interest rates than traditional CDs, but they do not compound interest. With Schwab CDs ...

Sanofi is aiming to sign an agreement this weekend to sell control of its consumer health business to Clayton Dubilier & Rice ...

Instead, you would sell your CD on the secondary market if you needed the money before your term ends. If you're looking to use CDs as part of your savings strategy, Edward Jones' brokered CDs may ...

Sanofis Exclusive Negotiations with Clayton Dubilier Rice Sanofi (NASDAQ: SNY) announced on Monday that it has entered ...

PARIS (Reuters) -French drugmaker Sanofi said on Monday it had entered exclusive talks to sell a 50% controlling stake in its ...